CME vs. Nu: Which Financial Stock Is a Better Buy for 2027?
CME boasts a 62% net margin and fortress balance sheet, while Nu's 43% revenue growth signals emerging-market momentum, but their risk profiles diverge sharply.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.